Ligand Pharmaceuticals Inc (LGND)
Operating Income Growth
1.74%
Quarterly · Period ending:
LGND Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported1.74%period ending
Latest reported1.74%period ending
LGND Quarterly Operating Income YoY % (26.79% → 1.74%)
Year-over-year change
High-resolution chart · PNG
LGND operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 1.7409% | |
| 147.9567% | |
| 307.9485% | |
| 1,647.7251% | |
| 144.2094% | |
| -1,312.0482% | |
| -186.9863% | |
| 2.1118% | |
| -863.1871% | |
| -78.9652% | |
| -127.5788% | |
| -75.0587% | |
| -122.8931% | |
| 565.9634% | |
| -4.382% | |
| -21.4249% | |
| -81.0621% | |
| -54.7614% | |
| 13.595% | |
| 319.162% | |
| 544.2113% | |
| 24.472% | |
| 210.1287% | |
| 172.6444% | |
| 271.9128% | |
| -99.5417% | |
| -130.7068% | |
| -122.0786% | |
| -105.8853% | |
| 2,131.4273% | |
| 16.9277% | |
| 41.648% | |
| 439.1856% | |
| 262.5783% | |
| 46.4738% | |
| 201.738% | |
| 197.4177% | |
| -32.3264% | |
| 75.699% | |
| -36.4197% | |
| 0.252% | |
| 350.7614% | |
| 14.3094% | |
| 143.4032% | |
| 221.4286% | |
| -34.3333% | |
| 49.9922% | |
| 15.0489% | |
| -10.3038% | |
| 29.705% | |
| 46.2887% | |
| 332.2239% | |
| 187.5145% | |
| 613.9869% | |
| -23.324% | |
| 61.1062% | |
| -113.5802% | |
| 65.5095% | |
| 196.0751% | |
| 78.3158% | |
| 77.6736% | |
| 44.9081% | |
| -575.0598% | |
| -2,125.1938% | |
| 22.0958% | |
| 44.985% | |
| 101.7101% | |
| 112.1794% | |
| 17.3265% | |
| 38.499% | |
| -812.5715% | |
| 27.155% | |
| 60.7894% | |
| 59.0297% | |
| -264.3237% | |
| 42.0909% | |
| -30.7188% | |
| 78.8163% | |
| 820.7658% | |
| -328.5917% | |
| -68.895% | |
| -769.3786% | |
| 94.3204% | |
| 9.5238% | |
| 42.237% | |
| -53.6139% | |
| -212.2535% | |
| 52.5873% | |
| -24.2007% | |
| 18.2838% | |
| 292.1689% | |
| -20.7308% | |
| 4.2744% | |
| -435.2791% | |
| -117.5893% | |
| -48.8704% | |
| -23.6138% | |
| 71.946% | |
| 73.598% | |
| 61.8717% |